Orchestra BioMed (OBIO) Institutional Ownership $5.33 -0.18 (-3.27%) As of 01/24/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Orchestra BioMed (NASDAQ:OBIO)CurrentInstitutional OwnershipPercentage53.55%Number ofInstitutional Buyers(last 12 months)12TotalInstitutional Inflows(last 12 months)$14.76MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$452.98K Get OBIO Insider Trade Alerts Want to know when executives and insiders are buying or selling Orchestra BioMed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data OBIO Institutional Buying and Selling by Quarter Orchestra BioMed Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/17/2025 SG Americas Securities LLC12,785$51K0.0%+26.0%0.034% 11/21/2024SkyView Investment Advisors LLC12,284$63K0.0%-38.6%0.032% 11/19/2024Barclays PLC31,785$163K0.0%+281.3%0.084% 11/16/2024Geode Capital Management LLC567,219$2.92M0.0%+2.0%1.492% 11/15/2024Barclays PLC31,785$163K0.0%+281.3%0.084% 11/15/2024Jane Street Group LLC19,070$98K0.0%-19.8%0.050% 11/15/2024State Street Corp429,613$2.21M0.0%+12.4%1.130% 11/15/2024RTW Investments LP8,206,159$42.18M0.6%+46.0%21.587% 11/13/2024The Manufacturers Life Insurance Company33,305$171K0.0%-20.9%0.088% 11/12/2024Charles Schwab Investment Management Inc.217,008$1.12M0.0%+3.9%0.574% Get the Latest News and Ratings for OBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Orchestra BioMed and its competitors with MarketBeat's FREE daily newsletter. 11/1/2024ABLE Financial Group LLC13,402$69K0.0%N/A0.035% 10/3/2024 SG Americas Securities LLC10,143$52K0.0%N/A0.028% 8/16/2024SkyView Investment Advisors LLC20,000$163K0.0%N/A0.056% 8/15/2024The Manufacturers Life Insurance Company42,082$343K0.0%+8.4%0.118% 8/1/2024Rhumbline Advisers26,439$215K0.0%+192.7%0.074% 7/26/2024Bank of New York Mellon Corp70,682$576K0.0%+115.7%0.197% 5/15/2024Price T Rowe Associates Inc. MD571,075$3.01M0.0%-8.3%1.596% 5/11/2024Catalytic Wealth RIA LLC22,261$117K0.0%N/A0.062% 2/1/2024New York State Common Retirement Fund3,623$33K0.0%-68.6%0.010% 10/27/2023Allspring Global Investments Holdings LLC4,904$43K0.0%N/A0.014% 10/27/2023TD Asset Management Inc92,678$808K0.0%+100.0%0.259% 10/24/2023Bank of New York Mellon Corp40,290$351K0.0%+211.2%0.113% 10/18/2023 UMB Bank n.a.3,160$28K0.0%N/A0.009% 10/13/2023 Arkadios Wealth Advisors51,595$450K0.0%N/A0.144% 8/24/2023Perceptive Advisors LLC2,052,868$14.37M0.4%-9.9%5.744% 8/11/2023Atika Capital Management LLC64,651$453K0.0%N/A0.181% 5/16/2023Boxer Capital LLC250,000$4.89M0.2%N/A2.230% 5/15/2023RTW Investments LP5,118,507$100.17M2.1%N/A45.652% 4/18/2023IFP Advisors Inc2,980$34K0.0%N/A0.027% (Data available from 1/1/2016 forward) OBIO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of OBIO shares? During the previous two years, 23 institutional investors and hedge funds held shares of Orchestra BioMed. The most heavily invested institutionals were RTW Investments LP ($42.18M), Perceptive Advisors LLC ($14.37M), Boxer Capital LLC ($4.89M), Price T Rowe Associates Inc. MD ($3.01M), Geode Capital Management LLC ($2.92M), State Street Corp ($2.21M), and Charles Schwab Investment Management Inc. ($1.12M).Learn more on OBIO's institutional investors. What percentage of Orchestra BioMed stock is owned by institutional investors? 53.55% of Orchestra BioMed stock is owned by institutional investors. Learn more on OBIO's institutional investor holdings. Which institutional investors have been buying Orchestra BioMed stock? Of the 19 institutional investors that purchased Orchestra BioMed stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RTW Investments LP ($7.70M), Boxer Capital LLC ($250K), Bank of New York Mellon Corp ($65.25K), Atika Capital Management LLC ($64.65K), Arkadios Wealth Advisors ($51.60K), State Street Corp ($47.31K), and Barclays PLC ($46.90K). How much institutional buying is happening at Orchestra BioMed? Institutional investors have bought a total of 8,395,316 shares in the last 24 months. This purchase volume represents approximately $121.50M in transactions. Which Orchestra BioMed major shareholders have been selling company stock? The following institutional investors have sold Orchestra BioMed stock in the last 24 months: Perceptive Advisors LLC ($225.36K), Price T Rowe Associates Inc. MD ($51.53K), The Manufacturers Life Insurance Company ($8.78K), New York State Common Retirement Fund ($7.93K), SkyView Investment Advisors LLC ($7.72K), and Jane Street Group LLC ($4.71K). How much institutional selling is happening at Orchestra BioMed? Institutional investors have sold a total of 306,027 shares in the last 24 months. This volume of shares sold represents approximately $2.03M in transactions. Related Companies BVS Institutional Ownership AVNS Institutional Ownership IRMD Institutional Ownership BFLY Institutional Ownership SIBN Institutional Ownership KIDS Institutional Ownership TMCI Institutional Ownership SMLR Institutional Ownership NNOX Institutional Ownership CLPT Institutional Ownership This page (NASDAQ:OBIO) was last updated on 1/26/2025 by MarketBeat.com Staff From Our PartnersNEW A.I. giant trading up to 84% less than MSFT – set to soar in 2025?I’ve traded every major tech boom since the dawn of the personal computer. And I can tell you one thing wit...The Oxford Club | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orchestra BioMed Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orchestra BioMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
